BPMC

Blueprint Medicines
BPMC

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$8.29B
EV
$8.11B
Shares Outstanding
67.59M
Beta
0.89

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$130.60
P/E 2025E
-
P/Revenue 2025E
11.51x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Blueprint Medicines Corporation

gainify
BPMC

Blueprint Medicines Corporation

BPMC

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastroi...

Sector

Healthcare

Industry

Biotechnology

CEO

Haviland, Kathryn

Employees

685

IPO Date

2015-04-30

Headquarters

45 Sidney Street, Cambridge, Massachusetts, 02139, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.